Search research articles
Contact Us
Filters
Showing results (401-410 of 504) with videos related to
Page
of 51
Sort By:
Journal for Immunotherapy of Cancer
|
August 11, 2025
Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors
Anthony K Park, Isabel Monroy, Yuwei Ren, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2018
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Monzr M Al Malki, Nitya Nathwani, Dongyun Yang, et al.
American Journal of Hematology
|
December 23, 2024
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma
Swetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, et al.
Transplantation and Cellular Therapy
|
June 14, 2024
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy
Ibrahim Aldoss, Haoyue Shan, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
Robert Chen, Alex F Herrera, Jessie Hou, et al.
Haematologica
|
June 16, 2018
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients
Ibrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2021
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
Ryotaro Nakamura, Wael Saber, Michael J Martens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 29, 2005
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation
Richard A Nash, Laura Johnston, Pablo Parker, et al.
Cancer
|
October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia
Ibrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Cancer Research
|
June 22, 2026
Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid Leukemia
David E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, et al.
Page
of 51
Search research articles
Search
Showing results (401-410 of 504) with videos related to
Sort By:
Page
of 51
Journal for Immunotherapy of Cancer
|
August 11, 2025
Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors
Anthony K Park, Isabel Monroy, Yuwei Ren, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2018
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Monzr M Al Malki, Nitya Nathwani, Dongyun Yang, et al.
American Journal of Hematology
|
December 23, 2024
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma
Swetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, et al.
Transplantation and Cellular Therapy
|
June 14, 2024
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy
Ibrahim Aldoss, Haoyue Shan, Dongyun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
Robert Chen, Alex F Herrera, Jessie Hou, et al.
Haematologica
|
June 16, 2018
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients
Ibrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2021
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
Ryotaro Nakamura, Wael Saber, Michael J Martens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 29, 2005
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation
Richard A Nash, Laura Johnston, Pablo Parker, et al.
Cancer
|
October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia
Ibrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Cancer Research
|
June 22, 2026
Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid Leukemia
David E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, et al.
Page
of 51